Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Humanigen Inc expected to post a loss of 86 cents a share - Earnings Preview

* Humanigen Inc  HGEN.OQ   HGEN.O  is expected to report
results on August 12 (estimated).
* The Burlingame, California-based company is expected to report
revenue of $35.976 million, according to the mean estimate from
5 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Humanigen Inc is for a
loss of 86 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Humanigen Inc
is $33.5​, about 47.5% above​ its last closing price
of $17.60. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.71       -0.64      -1.25     Missed  -95.3
 Dec. 31 2020  -0.68       -0.67      -0.63     Beat    6.3
 Sep. 30 2020  -0.57       -0.57      -0.71     Missed  -25.3​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 10 at 23:35 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Humanigen

See all news